
    
      This is a a real world registry study. All patients with hypertension in community hospitals
      in China will be eligible . Patient demographics, medical history, clinical characteristics,
      physical examination, laboratory tests (including UCAR, blood routine, urine routine, blood
      biochemistry, and ECG), antihypertensive drugs (including: ACEI/ ARB, thiazide diuretics,
      CCB, beta-blockers, alpha-blockers, and other antihypertensive drugs used in real-life
      clinical practice in other communities.) will be recorded. All patients are anticipated to be
      followed up for 12-month. Effectiveness of different antihypertensive medications on Urine
      Albumin-to-Creatinine Ratio (UACR) will be evaluted.
    
  